Skip to main content
SpringerLink
Log in

Antikörpernachweis bei Serratia marcescens-Infektionen

Antibody detection in infections with serratia marcescens

  • Originalia
  • Published:
Infection Aims and scope Submit manuscript

Zusammenfassung

Es wird über den Nachweis von Antikörpern gegen die homologen Stämme bei Serratia marcescens-Infektionen unter Heranziehung der Agglutination und Präzipitation berichtet. Die Untersuchungsergebnisse sprechen dafür, daß mit Antikörperbildung gerechnet werden muß, wenn invasive Verlaufsformen vorliegen. Die Agglutinationstiter lagen zwischen 1:40 und 1:640. Es ist anzunehmen, daß neben den gegen das O-Antigen gerichteten Antikörpern vom Patienten auch solche gebildet werden, die sich gegen bestimmte Antigene mit Ferment- und Toxincharakter richten.

Summary

A report is given on the detection by agglutination and precipitation of antibodies against homologous strains in infections with Serratia marcescens. The results of the investigation indicate that antibody formation is likely if invasive forms are present. The agglutination titers were between 1:40 and 1:640. It can be presumed that, in addition to the patient's antibodies against the O antigen, antibodies are also formed against certain antigens with the character of ferments or toxins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Baumann, W., Emmrich, P. Sepsis und andere Infektionen durch Serratia marcescens im Neugeborenen- und Säuglingsalter. Dtsch. med. Wschr. 99 (1974) 1755–1760.

    Article  CAS  PubMed  Google Scholar 

  2. Black, W. A., Hodgson, R. Search for Serratia. J. clin. Path 24 (1971) 444–448.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Burdin, J.-C., Lochard, J., Schaack, F., Edert, M., Georges, J.-C. Epidémie d'infections pleuro-pulmonaires dues a „Serratia marcescens“ en milieu hospitalier. Presse med. 75 (1967) 466–468.

    CAS  PubMed  Google Scholar 

  4. Burger, G. Serratia marcescens BIZIO 1823. Zbl. Bakt. I. Ref. 207 (1967) 365–438.

    Google Scholar 

  5. Caselitz, F.-H. Panoramawechsel in der Bakteriologie. Mat. Med. Nordm. 23 (1971) 185–195.

    Google Scholar 

  6. Clayton, E., von Graevenitz, A. Nonpigmented Serratia marcescens. J. Amer. med. Ass. 197 (1966) 1059–1064.

    Article  CAS  Google Scholar 

  7. Crowder, J. G., Gilkey, G. H., White, A. C. Serratia marcescens, Bacteremia. Arch. Intern. Med. 128 (1971) 247–252.

    Article  CAS  PubMed  Google Scholar 

  8. Davis, J. T., Foltz, E., Blakemore, W. S. Serratia marcescens — A pathogen of increasing clinical importance. J. Amer. med. Ass. 214 (1970) 2190–2192.

    Article  CAS  Google Scholar 

  9. Edwards, P. R., Ewing, W. H. Identification of Enterobacteriaceae. Burgess Publishing Company, Mineapolis (1972).

    Google Scholar 

  10. von Graevenitz, A. Über Serratia-Infektionen beim Menschen. Path. Microbiol. 27 (1964) 235–247.

    Google Scholar 

  11. von Graevenitz, A., Buchholz, D. Occurence of Serratia marcescens in soft tissue infections. In: Bayer-Symposium III, p 133–142, Springer, Stuttgart 1971.

    Google Scholar 

  12. Modde, H. Durch Serratia marcescens („Prodigiosus“) verursachte Krankheiten. Schweiz. med. Wschr. 102 (1972) 1386.

    CAS  PubMed  Google Scholar 

  13. Nowotny, A. M., Scott, T., Duron, O. S., Nowotny, A. H. Relation of structure to function in bacterial O antigens. I. Isolation methods. J. Bact. 85 (1963) 418–426.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Paine, T. F. Ilness in man following inhalation of Serratia marcescens. J. Infect. Dis. (Chicago) 79 (1946) 226 bis 232.

    Article  Google Scholar 

  15. Reitmann, M., Sutton, L. S., Alg, R. L., Miller, W. S., Gross, N. H. Agglutinins in sera of laboratory workers exposed to Serratia marcescens. Proc. Soc. exp. Biol. 89 (1955) 236–240.

    Article  Google Scholar 

  16. Sedlák, J., Rische, H. Enterobacteriaceae-Infektionen. Thieme, Leipzig 1968.

    Google Scholar 

  17. Traub, W. H., Raymond, E. A. Epidemiological surveillance of Serratia marcescens infections by bacteriocin typing. Appl. Microbiol. 22 (1971) 1058–1063.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Wilfert, J. N., Barrett, F. F., Kass, E. H. Bacteremia due to Serratia marcescens. N. Engl. J. Med. 279 (1968) 286–289.

    Article  CAS  PubMed  Google Scholar 

  19. Wilfert, J. N., Barrett, F. F., Ewing, W. H., Finland, M., Kass, E. H. Serratia marcescens: Biochemical, serological and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital. Appl. Microbiol. 19 (1970) 345–352

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Wilkowske, C. J., Washington, J. A., Martin, W. J., Ritts, R. E. Serratia marcescens — biochemical characteristics, antibiotic susceptibility patterns and clinical significance. J. Amer. med. Ass. 214 (1970) 2157–2162.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bakteriologische Abteilung des Allgemeinen Krankenhauses Altona, Paul-Ehrlich-Str. 1, D-2000, Hamburg 50, Germany

    V. Freitag &  F. -H. Caselitz

Authors
  1. V. Freitag
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. -H. Caselitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Freitag, V., Caselitz, F.H. Antikörpernachweis bei Serratia marcescens-Infektionen. Infection 3, 74–77 (1975). https://doi.org/10.1007/BF01641045

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01641045

Search

Navigation